Hjem › Type 2-diabetes › Virginia › Arlington
Type 2-diabetes kliniske forsøg i Arlington, VA
15 studier for Type 2-diabetes søger deltagere på steder i og omkring Arlington (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Carient Heart and Vascular LLC-Reston, Reston · 14 mi væk
- Carient Heart & Vascular - Manassas, Manassas · 22 mi væk
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- Seven Corners Medical Center, Falls Church · 4 mi væk
- Carient Heart and Vascular, Manassas · 22 mi væk
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Manassas · 22 mi væk
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
- Research Site, Manassas · 22 mi væk
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RekruttererFase 2
- Conquest Research - Arlington, Vienna · 9 mi væk
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekruttererFase 3
- Manassas Clinical Research Center, Manassas · 22 mi væk
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RekruttererFase 2
- Conquest Research, Vienna · 9 mi væk
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekruttererFase 3
- Manassas Clinical Research Center Inc, Manassas · 22 mi væk
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RekruttererFase 3
- Carient Heart and Vascular, Manassas · 22 mi væk
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Arlington
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
RekruttererObservationsstudie
- Research Site, Potomac · 11 mi væk
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
RekruttererFase 2
- Manassas Clinical Research Center, Manassas · 22 mi væk
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
RekruttererFase 3
- Research Site, Potomac · 11 mi væk
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RekruttererFase 2
- Burke Internal Medicine and Research, Burke · 11 mi væk
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
RekruttererFase 2
- Burke Internal Medicine & Research, Burke · 11 mi væk
Type 2-diabetes forsøg i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
Andre studier i Arlington
- Ikke-småcellet lungecancer104 studier
- Metastatisk cancer53 studier
- Colorektal kræft52 studier
- Kræft (alle typer)48 studier
- Brystkræft46 studier
- Ægstockræft46 studier
- Lungecancer41 studier
- Livmoderslimhindekræft39 studier
- Bugspytkirtelkræft33 studier
- Pladecellekræft i hoved og hals26 studier
- Småcellet lungekræft23 studier
- Tripelnegativ brystkræft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.